Focal hyperhidrosis: Diagnosis and management

CMAJ. Canadian Medical Association Journal

Volumn 172, Issue 1, 2005, Pages 69-75

  Haider, Aamir ^a   Solish, Nowell ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM CHLORIDE; ALUMINUM SALT; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; FORMALDEHYDE; GLUTARALDEHYDE;

CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FEEDBACK SYSTEM; HUMAN; HYPERHIDROSIS; INJECTION PAIN; IONTOPHORESIS; LUMBAR SYMPATHECTOMY; MEDICAL SPECIALIST; PATHOPHYSIOLOGY; PATIENT REFERRAL; PATIENT SATISFACTION; REVIEW; SWEAT GLAND; TREATMENT CONTRAINDICATION;

EID: 12344251121     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1040708     Document Type: Review

References (44)

1. Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y. Impairment in quality of life among patients seeking surgery for hyperhidrosis (excessive sweating): preliminary results. Isr J Psychiatry Relat Sci 2000;37(1):25-31.
2. Lerer B, Jacobowitz J, Wahaba A. Personality features in essential hyperhidrosis. Int J Psychiatry Med 1981;10:59-67.
3. Christophers E, Kruger G. Psoriasis. In: Fitzpatrick TB, Eisen AZ, Wolff K, editors. Dermatology in general medicine. 3rd ed. New York: McGraw-Hill; 1987. p. 465.
4. Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosisand impact on individuals with axillary hyperhidrosis: Results from a national survey. J Am Acad Dermatol 2004;51(2):241-8.
5. Lin TS, Fang HY. Transthoracic endoscopie sympathectomy in the treatment of palmar hyperhidrosis - with emphasis on perioperative management (1360 case analysis). Surg Neurol 1999;52:453-7.
6. Kinkelin I, Hund M, Naumann M, Hamm H. Effective treatment of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol 2000;143(4):824-7.
7. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat glands and their disorders H. Disorders of sweat gland function. J Am Acad Dermatol 1989;20(5 Pt 1):713-26.
8. Sato K, Kang WH, Saga KT. Biology of sweat glands and their disorders I. Normal sweat gland function. J Am Acad Dermatol 1989;20(4):537-63.
9. Stolman LP. Treatment of hyperhidrosis. Dermatol Clin 1998;16:863-7.
10. Shih CJ, Wu JJ, Lin MT. Autonomie dysfunction in palmar hyperhidrosis. J Auton Nerv Syst 1983;8:33-43.
11. Birner P, Heinzl H, Schindl M, Pumprla J, Schnider P. Cardiac autonomie function in patients suffering from primary focal hyperhidrosis. Eur Neurol 2000;44(2):112-6.
12. Boni R. Generalized hyperhidrosis and its systemic treatment. Curr Probl Dermatol 2002;30:44-7.
13. Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, et al; Multi-Specialty Working Group on the Recognition, Diagnosis and Treatment of Primary Focal Hyperhidrosis. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004;51:274-86.
14. Goh CL. Aluminum chloride hexahydrate versus palmar hyperhidrosis, evaporimeter assessment. Int J Dermatol 1990;29:368-70.
15. Scholes KT, Crow KD, Ellis JP, Harman RR, Saihan EM. Axillary hyperhidrosis treated with alcoholic solution of aluminum chloride hexahydrate. BMJ 1978;2:84-5.
16. Karakoc Y, Aydemir EH, Kalkan MT, Unal G, et al. Safe control of palmoplantar hyperhidrosis with direct electrical current. Int J Dermatol 2002;41(9):602-5.
17. Reinauer S, Neusser A, Schauf G, Holzle E. Iontophoresis with alternating current and direct current offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol 1993;129(2):166-9.
18. Holzle E, Alberti N. Long term efficacy and side effects of tap water iontophoresis of palmoplantar hyperhidrosis - the usefulness of home therapy. Dermatologica 1987;175:126-35.
19. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis. N Engl J Med 2001;344:488-93.
20. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: a randomised, parallel group, double blind, placebo controlled trial. BMJ 2001;323:596-9.
21. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S. Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: A double blind randomized placebo controlled study. Dermatol Surg 2002;28(9):822-7.
22. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K. Double blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol 1997;136(4):548-52.
23. Doolabh N, Horswell S, Williams M, Huber L, Prince S, Meyer DM, et al. Thoracoscopic sympathectomy for hyperhidrosis: indications and results. Ann Thorac Surg 2004;77(2):410-4.
24. Reisfeld R, Nguyen R, Pnini A. Endoscopic thoracic sympathectomy for hyperhidrosis. Surg Laparosc Endosc Percutane Tech 2002;12(4):255-67.
25. Zacherl J, Imhof M, Huber ER, Plas EG, Herbst F, Jakesz R, Video assistance reduces complication rate of thoracoscopic sympathectomy for hyperhidrosis. Ann Thorac Surg 1999;68(4):1177-81.
26. Proebstle TM, Schneiders V, Knop J. Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis. Dermatol Surg 2002;28(11):1022-6.
27. Holzle E, Kligman AM. Mechanism of antiperspirant action of aluminum salts. J Soc Cosm Chem 1979;30:279-95.
28. Shelly WB, Hurley HJ. Studies on topical antiperspirant control of axillary hyperhidrosis. Acta Derm Venereol (stockh) 1975;55:241-60.
29. White JW. Treatment of primary hyperhidrosis. Mayo Clin Proc 1986;61:951-6.
30. Sato K, Timm DE, Sato F, Templeton EA, Meletiou DS, Toyomoto T, et al. Generation and transit pathway of H+ is critical for inhibition of palmar sweating by iontophoresis in water. J Appl Physiol 1993;75(5):2258-64.
31. Bouman H. The treatment of hyperhidrosis of hands and feet with constant current. Am J Phys Med 1952;31:158-69.
32. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin. Ann Rev Pharmacol Toxicol 1986;26:427-53.
33. Pearson C, Cliff S. Botulinum toxin type A treatment for axillary hyperhidrosis: a comparison of intradermal and subcutaneous injection techniques. Br J Dermatol 2004;151(suppl 68):95.
34. Connolly M, de Berker D. Management of primary hyperhidrosis. Am J Clin Dermatol 2003;4(10):681-97.
35. Naumann M. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998;134(3):301-4.
36. Sevim S, Dogu O, Kaleagasi H. Botulinum toxin A therapy for palmar and plantar hyperhidrosis. Acta Neurol Belg 2002;102(4):167-70.
37. Vodoud-Seyedi J, Simonart T, Heen T. Treatment of plantar hyperhidrosis with dermojet injections of botulinum toxin. Dermatology 2000;201(2):179.
38. Jemec B. Abrasio axillae in hyperhidrosis. Scand J Plast Reconstr Surg 1975;9:44-6.
39. Lillis PJ, Coleman WP. Liposuction for the treatment of axillary hyperhidrosis. Dermatol Clin 1990;8:479-82.
40. Eedy DJ, Corbett JR. Olfactory facial hyperhidrosis responding to amitriptyline. Clin Exp Dermtol 1978;12:298-9.
41. Tkach JR. Indomethacin treatment of generalized hyperhidrosis. J Am Acad Dermatol 1982;6:545.
42. Feder R. Clonidine treatment of excessive sweating. J Clin Psychiatry 1995;56:35.
43. Duller P, Gentry WD. Use of biofeedback in treating chronic hyperhidrosis: a preliminary report. Br J Dermatol 1980;103:143-6.
44. Shenefelt PD. Hypnosis in dermatology. Arch Dermatol 2000;136:393-9.